Abstract

The aim of this investigation is to study the effect of BTA on the cerebral blood flow in patients with chronic daily headache. The analysis of Doppler ultrasonography and transcranial Dopplergraphy findings has shown the following: after the treatment 34% of the patients had no extravasal effect and in 66% of the patients it became moderate and after the treatment normal venous outflow was found in 58% of the patients . The results of the pilot study demonstrate the effect of BT-A injection on the cerebral blood flow by means of optimizing both the arterial blood flow and the venous outflow from the cavity of the skull.

Highlights

  • Для терапии хронической ежедневной головной боли (ХЕГБ) использовали препарат диспорт

  • The aim of this investigation is to study the effect of BTA on the cerebral blood flow in patients with chronic daily headache

  • The analysis of Doppler ultrasonography and transcranial Dopplergraphy findings has shown the following: after the treatment 34% of the patients had no extravasal effect and in 66% of the patients it became moderate and after the treatment normal venous outflow was found in 58% of the patients

Read more

Summary

Introduction

Для терапии хронической ежедневной головной боли (ХЕГБ) использовали препарат диспорт. При ХЕГБ, развивающейся из трансформированной мигрени, этот фактор связан с экстракраниальной артериальной вазодилатацией, которая активирует вторичный механизм — растяжение нервных волокон, вовлеченных в процесс передачи боли, окружающих кровеносные сосуды, что приводит к нейрогенному воспалению. Впервые эффективность БТА при головной боли была отмечена пластическим хирургом W.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call